Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL

Summary

This is a single center, single arm, open-lable phase I study to determine the safety and efficacy of T cells expressing CD7 chimeric antigen receptors (referred to as "BT-007 CAR-T cells") in patients with relapsed or refractory acute T cell lymphoblastic lymphoma (R/R T-LBL).

Timeline

Start

2022-10

Primary completion

2024-09

Completion

2024-09

Drugs

Indications